Corpus Intelligence IC Memo — CONTINUECARE HOSPITAL AT UNIVERSITY 2026-04-26 12:37 UTC
IC Memo — CONTINUECARE HOSPITAL AT UNIVERSITY
Investment Committee Memorandum | NC | 17 beds | Grade D | EBITDA uplift $359K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CONTINUECARE HOSPITAL AT UNIVERSITY

CCN 342021 | MECKLENBURG, NC | 17 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

CONTINUECARE HOSPITAL AT UNIVERSITY is a 17-bed community hospital in MECKLENBURG, NC with $4.7M in net patient revenue and a -43.8% operating margin. The hospital serves a payer mix of 52.6% Medicare, 0.0% Medicaid, and 47.4% commercial.

Thesis: Turnaround. Our ML models identify $359K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -43.8% to -36.2% (+762bps).

Net Revenue HCRIS$4.7M
Current EBITDA COMPUTED$-2.1M
Operating Margin COMPUTED-43.8%
Occupancy HCRIS69.9%
Revenue / Bed COMPUTED$277K
Net-to-Gross HCRIS25.4%
Distress Probability MLnan%

2. Market Context & Competitive Position

129
NC Hospitals
-2.0%
State Median Margin
27
Comparable Hospitals

NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of -43.8% places it below the state median. Among 27 size-comparable peers (8-34 beds), the median margin is -7.7%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-34), prioritizing same-state peers. 27 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CONTINUECARE HOSPITAL AT UNIVE (Target)NC17$4.7M-43.8%
THE OUTER BANKS HOSPITALNC21$93.7M26.2%
MEDICAL PARK HOSPITALNC22$82.6M15.8%
NORTH CAROLINA SPECIALTY HOSPINC18$71.6M11.7%
THE MCDOWELL HOSPITALNC30$65.7M-6.7%
CHOWAN HOSPITAL INC.NC25$61.5M10.4%
MURPHY MEDICAL CENTERNC25$58.0M-8.8%
J ARTHUR DOSHER MEMORIAL HOSPINC25$57.6M3.8%
ST LUKES HOSPITALNC25$50.4M-1.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $359K (762bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Denial Rate Reduction12.0%6.5%$99K+210bp12mo
Net Collection Rate93.5%97.0%$99K+210bp18mo
Cost to Collect4.5%2.5%$94K+200bp12mo
A/R Days Reduction5200.0%3800.0%$57K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+20bp6mo

5. EBITDA Bridge

Denial Rate Reduction
$99K
Net Collection Rate
$99K
Cost to Collect
$94K
A/R Days Reduction
$57K
Clean Claim Rate
$10K
Total EBITDA Uplift$359K
Current EBITDA$-2.1M
+ RCM Uplift+$359K
Pro Forma EBITDA$-1.7M
Current Margin-43.8%
Pro Forma Margin-36.2%
WC Released (1x)$181K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-3.2M$-10.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-3.2M$-12.1M0.00x-100.0%
Bull Case9.0x11.0x$-2.9M$-11.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.9M$-13.8M0.00x-100.0%
Bear Case11.0x10.0x$-3.5M$-10.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.5M$-13.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 27 hospitals with 8-34 beds
  • Same-state prioritization (n=28)
  • Comp margins: P25=-19.3% / P50=-7.7% / P75=3.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.